Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy

Colleen M. O'Connor(The University of Texas MD Anderson Cancer Center), Laurence J.N. Cooper(The University of Texas MD Anderson Cancer Center)
Scientific Reports
February 13, 2012
10.1038/srep00249
Cited by 71

Related Papers

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
|Journal of Clinical Investigation|2016|499
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
|Proceedings of the National Academy of Sciences|2016|452
Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
|Cancer Research|2011|199
Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells
|PLoS ONE|2013|171